CoChat

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study

Open access
Alkharfy, Khalid M, Al-Daghri, Nasser M, Sabico, Shaun B, Al-Othman, Abdulaziz, Moharram, Osama, Alokail, Majed S, Al-Saleh, Yousef, Kumar, Sudhesh, Chrousos, George P · 2013 · Cardiovascular Diabetology

Abstract

BACKGROUND: Little or no research has determined the effect of vitamin D3 supplementation in conjunction with pharmacological and non-pharmacological approaches in the diabetes mellitus type 2 (DMT2) patients. The objective of this study was to determine the effect of vitamin D3 supplementation in a cohort of Saudi DMT2 population on diet, insulin and/or different oral hypoglycemic agents and compare them with a non-DMT2 control cohort. METHODS: A total of 499 randomly selected Saudi subjects divided into 8 groups [Non-DMT2 Control = 151; Rosiglitazone alone = 49; Diet = 15; Insulin alone = 55; Insulin + Orals = 12; Metformin alone = 121; Oral agents combination = 37; Sulphonylurea alone = 59] were included in this 12-month interventional study. All DMT2 patients were given 2000 IU vitamin D3 daily, while the control group received none but were advised to increase sun exposure. Anthropometrics, glucose, lipid profile and 25-hydroxyvitamin D (25-OHVitD) were measured at baseline, 6 and 12 months. RESULTS: Circulating 25-OHVitD concentrations improved in all patient groups. The metformin group showed the highest change in circulating vitamin D levels both at 6 months (62.6%) and 12 months (50.6%) as compared to baseline (p < 0.001). No significant changes were observed in the BMI and glucose in any of the DMT2 groups. In contrast, the insulin + oral agents group showed more significant improvements in the metabolic profile, which included triglycerides and total cholesterol, as well as systolic blood pressure and HDL-cholesterol in males. Also, significant decreases in triglycerides were observed in the rosiglitazone and insulin + oral hypoglycemic agent groups both at 6 and 12 months of supplementation (both p-values <0.001). CONCLUSION: While in all DMT2 groups circulating levels of 25-OHVitD increased after supplementation, in DMT2 patients on insulin in combination with other drugs benefitted the most in improving cardiovascular risk. Metformin improves 25-hydroxyvitamin D levels but did not seem to confer other added cardiometabolic benefits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2840-12-113

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Circulating 25-Hydroxyvitamin D Levels in A. DMT2 Males and Females and B. Non-DMT2 Control Males and Females.
Figure 1 Circulating 25-Hydroxyvitamin D Levels in A. DMT2 Males and Females and B. Non-DMT2 Control Males and Females.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 1

  1. 10.2337/diabetes.46.10.1601 · DOI

Cited by

See all 47

Metadata

Authors
Alkharfy, K. M., Al-Daghri, N. M., Sabico, S. B., Al-Othman, A., Moharram, O., Alokail, M. S., Al-Saleh, Y., Kumar, S., & Chrousos, G. P.
Affiliations
  • King Saud University (SA)
  • University Hospital Coventry (GB)
  • National and Kapodistrian University of Athens (GR)
Corresponding author
Alkharfy, Khalid M
Venue
Cardiovascular Diabetology
Published
2013
Volume
12
Issue
1
Pages
113
ISSN
1475-2840 (ISSN-L)
OpenAlex
W1981230812
Cited by
47
References
24
Citations by year
2024: 3 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 11 · 2014: 11
FWCI
5.98
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
vitamin D3 supplementation, type 2 diabetes, 25-hydroxyvitamin D, metformin, insulin therapy, oral antidiabetic drugs, rosiglitazone, sulfonylureas, triglycerides, cardiovascular risk, lipid profile, sun exposure, Saudi patients
MeSH terms
Rosiglitazone, Administration, Oral, Adult, Blood Glucose, Cholecalciferol, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Humans, Hypoglycemic Agents, Insulin, Lipids, Male, Metformin, Middle Aged, Prospective Studies, Saudi Arabia, Sulfonylurea Compounds, Vitamin D, Biomarkers, Case-Control Studies, Treatment Outcome, Dietary Supplements, Thiazolidinediones, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. https://app.cochat.ai/papers/10.1186/1475-2840-12-113
The paper
Alkharfy, K. M., Al-Daghri, N. M., Sabico, S. B., Al-Othman, A., Moharram, O., Alokail, M. S., Al-Saleh, Y., Kumar, S., & Chrousos, G. P. (2013). Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovascular Diabetology. https://doi.org/10.1186/1475-2840-12-113

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.